At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 55 enrolled
Drug / intervention
Topiramate add-on therapy +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Topiramate in the Treatment of Epilepsy: 1st Add-on vs. Mono-therapy Study in Neuro-Surgical Patients
In Brief
A Phase 4 clinical trial evaluating Topiramate add-on therapy and Topiramate monotherapy for Epilepsy. Completed, enrolled 55 participants.
Detailed Summary
The purpose of this study is to examine seizure control and tolerability of Topiramate after either transitioning from previous antiepileptic drug (AED) or adding on to previous AED.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEpilepsy
Countries--
Collaborators--
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2010
Primary CompletionJan 2011
First PostedJun 2012
TodayJul 2026
First PostedJun 26, 2012
Enrollment StartFeb 1, 2010
Primary CompletionJan 1, 2011
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 14.0 years ago
Interventions
Topiramate add-on therapydrug
Type=range, unit=mg/day, number=25-200, form=tablet, route=oral use.
Topiramate monotherapydrug
Type= range, unit= mg/day, number= 25-200, form= tablet, route= oral use.